Gabon vs South Africa: Population requiring preventive chemotherapy for schistosomiasis
Gabon
204,568
in 2024
South Africa
506,732
in 2024
Gabon rank
42nd
South Africa rank
39th
Population requiring preventive chemotherapy for schistosomiasis over time
- Gabon
- South Africa
How they compare
South Africa currently reports 506,732 against 204,568 in Gabon, a difference of 302,164.
That makes South Africa's figure about 2.5 times Gabon's.
Across all 15 years both countries report, South Africa has been ahead every year.
Gabon ranks 42nd and South Africa ranks 39th of 52 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gabon | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 274,188 | 5.28 million | 5.01 million | South Africa |
| 2020s | 192,392 | 2.98 million | 2.79 million | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Gabon or South Africa?
- South Africa, at 506,732 against 204,568 in Gabon as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Gabon and South Africa?
- 302,164, with South Africa ahead.
- How many years of comparable data are there for Gabon and South Africa?
- 15 years are reported by both, from 2010 to 2024.
- How do Gabon and South Africa rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Gabon ranks 42nd and South Africa ranks 39th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.